Your browser doesn't support javascript.
loading
Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma.
Tai, Cheng-Jeng; Huang, Ming-Te; Wu, Chih-Hsiung; Wang, Chien-Kai; Tai, Chen-Jei; Chang, Chun-Chao; Hsieh, Cheng-I; Chang, Yu-Jia; Wu, Chang-Jer; Kuo, Li-Jen; Wei, Po-Lei; Chen, Ray-Jade; Chiou, Hung-Yi.
Afiliación
  • Tai CJ; From the Division of Hematology and Oncology, Department of Internal Medicine, Taipei Medical University Hospital (C-JT, C-KW, C-CC, C-IH); Department of Internal Medicine (C-JT, C-KW, C-IH); Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University (M-TH, L-JK, P-LW, RJC); Division of General Surgery, Department of Surgery, Shuang Ho Hospital (M-TH, C-HW); Center of Excellence for Cancer Research, Taipei Medical University (C-HW); Department of Surgery, Taipei Me
Medicine (Baltimore) ; 95(15): e3259, 2016 Apr.
Article en En | MEDLINE | ID: mdl-27082562
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Cetuximab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Medicine (Baltimore) Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Cetuximab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Medicine (Baltimore) Año: 2016 Tipo del documento: Article